Cargando…
Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions
In this Viewpoint, the authors explore the determinants of patients’ prescription adherence behaviors as part of FIND's Advancing Access to Diagnostic Innovation essential for Universal Health Coverage and AMR Prevention (ADIP) trials (ClinicalTrials.gov identifier: NCT04081051). Research findi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368411/ https://www.ncbi.nlm.nih.gov/pubmed/37490738 http://dx.doi.org/10.1093/cid/ciad323 |
_version_ | 1785077500147138560 |
---|---|
author | Compaoré, Adélaïde Ekusai-Sebatta, Deborah Kaawa-Mafigiri, David Kukula, Vida Odopey, Selase Kapisi, James Hopkins, Heidi Kiemde, François Tinto, Halidou Baiden, Rita Olliaro, Piero Nkeramahame, Juvenal Dittrich, Sabine Horgan, Philip |
author_facet | Compaoré, Adélaïde Ekusai-Sebatta, Deborah Kaawa-Mafigiri, David Kukula, Vida Odopey, Selase Kapisi, James Hopkins, Heidi Kiemde, François Tinto, Halidou Baiden, Rita Olliaro, Piero Nkeramahame, Juvenal Dittrich, Sabine Horgan, Philip |
author_sort | Compaoré, Adélaïde |
collection | PubMed |
description | In this Viewpoint, the authors explore the determinants of patients’ prescription adherence behaviors as part of FIND's Advancing Access to Diagnostic Innovation essential for Universal Health Coverage and AMR Prevention (ADIP) trials (ClinicalTrials.gov identifier: NCT04081051). Research findings from Burkina Faso, Ghana, and Uganda show that basic knowledge and understanding of prescription instructions are essential for adherence and can be improved through better communication. However, there are a range of other factors that influence adherence, some of which can be influenced through tailored communication messages from healthcare workers. These messages may contribute to changes in adherence behavior but may require other reinforcing interventions to be effective. Finally, there are some drivers of nonadherence centered around costs and time pressure that require other forms of intervention. |
format | Online Article Text |
id | pubmed-10368411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103684112023-07-26 Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions Compaoré, Adélaïde Ekusai-Sebatta, Deborah Kaawa-Mafigiri, David Kukula, Vida Odopey, Selase Kapisi, James Hopkins, Heidi Kiemde, François Tinto, Halidou Baiden, Rita Olliaro, Piero Nkeramahame, Juvenal Dittrich, Sabine Horgan, Philip Clin Infect Dis Supplement Article In this Viewpoint, the authors explore the determinants of patients’ prescription adherence behaviors as part of FIND's Advancing Access to Diagnostic Innovation essential for Universal Health Coverage and AMR Prevention (ADIP) trials (ClinicalTrials.gov identifier: NCT04081051). Research findings from Burkina Faso, Ghana, and Uganda show that basic knowledge and understanding of prescription instructions are essential for adherence and can be improved through better communication. However, there are a range of other factors that influence adherence, some of which can be influenced through tailored communication messages from healthcare workers. These messages may contribute to changes in adherence behavior but may require other reinforcing interventions to be effective. Finally, there are some drivers of nonadherence centered around costs and time pressure that require other forms of intervention. Oxford University Press 2023-07-25 /pmc/articles/PMC10368411/ /pubmed/37490738 http://dx.doi.org/10.1093/cid/ciad323 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Article Compaoré, Adélaïde Ekusai-Sebatta, Deborah Kaawa-Mafigiri, David Kukula, Vida Odopey, Selase Kapisi, James Hopkins, Heidi Kiemde, François Tinto, Halidou Baiden, Rita Olliaro, Piero Nkeramahame, Juvenal Dittrich, Sabine Horgan, Philip Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title | Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title_full | Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title_fullStr | Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title_full_unstemmed | Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title_short | Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions |
title_sort | viewpoint: antimicrobial resistance diagnostics use accelerator: qualitative research on adherence to prescriptions |
topic | Supplement Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368411/ https://www.ncbi.nlm.nih.gov/pubmed/37490738 http://dx.doi.org/10.1093/cid/ciad323 |
work_keys_str_mv | AT compaoreadelaide viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT ekusaisebattadeborah viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT kaawamafigiridavid viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT kukulavida viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT odopeyselase viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT kapisijames viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT hopkinsheidi viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT kiemdefrancois viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT tintohalidou viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT baidenrita viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT olliaropiero viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT nkeramahamejuvenal viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT dittrichsabine viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT horganphilip viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions AT viewpointantimicrobialresistancediagnosticsuseacceleratorqualitativeresearchonadherencetoprescriptions |